We further analyzed the correlation between SLC22A8 expression and immune cell markers using the TIMER and GEPIA databases, including B cells, CD8+ T cells, M1/M2 macrophages, tumor-associated macrophages (TAMs), neutrophils, natural killer cells, and dendritic cells in KIRC. This evidence concerns the gene SLC22A8 and neoplasm.